Commentary: Effect of fecal microbiota transplantation on non-alcoholic fatty liver disease: A randomized clinical trial
- PMID: 36439219
- PMCID: PMC9685304
- DOI: 10.3389/fcimb.2022.1056394
Commentary: Effect of fecal microbiota transplantation on non-alcoholic fatty liver disease: A randomized clinical trial
Keywords: diet therapy long-term efficacy; exercise therapy; fecal microbiota transplantation (FMT); gut microbiota; lifestyle interventions; non-alcoholic fatty liver disease (NAFLD).
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
-
Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial.Front Cell Infect Microbiol. 2022 Jul 4;12:759306. doi: 10.3389/fcimb.2022.759306. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35860380 Free PMC article. Clinical Trial.
Similar articles
-
Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial.Front Cell Infect Microbiol. 2022 Jul 4;12:759306. doi: 10.3389/fcimb.2022.759306. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35860380 Free PMC article. Clinical Trial.
-
Fecal microbiota transplantation for treatment of non-alcoholic fatty liver disease: Mechanism, clinical evidence, and prospect.World J Gastroenterol. 2024 Feb 28;30(8):833-842. doi: 10.3748/wjg.v30.i8.833. World J Gastroenterol. 2024. PMID: 38516241 Free PMC article. Review.
-
Mechanistic and physiological approaches of fecal microbiota transplantation in the management of NAFLD.Inflamm Res. 2021 Jul;70(7):765-776. doi: 10.1007/s00011-021-01480-z. Epub 2021 Jul 1. Inflamm Res. 2021. PMID: 34212214 Review.
-
Faecal Microbiota Transplantation, Paving the Way to Treat Non-Alcoholic Fatty Liver Disease.Int J Mol Sci. 2023 Mar 24;24(7):6123. doi: 10.3390/ijms24076123. Int J Mol Sci. 2023. PMID: 37047094 Free PMC article. Review.
-
Faecal Microbiota transplantation affects liver DNA methylation in Non-alcoholic fatty liver disease: a multi-omics approach.Gut Microbes. 2023 Dec 31;15(1):2223330. doi: 10.1080/19490976.2023.2223330. Gut Microbes. 2023. PMID: 37317027 Free PMC article.
Cited by
-
The Intestinal Microbiome and the Metabolic Syndrome-How Its Manipulation May Affect Metabolic-Associated Fatty Liver Disease (MAFLD).Curr Issues Mol Biol. 2023 Aug 31;45(9):7197-7211. doi: 10.3390/cimb45090455. Curr Issues Mol Biol. 2023. PMID: 37754239 Free PMC article. Review.
References
-
- Boursier J., Mueller O., Barret M., Machado M., Fizanne L., Araujo-Perez F., et al. . (2016). The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology. 63, 764–775. doi: 10.1002/hep.28356 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical